• 목록
• 답변
• 글쓰기
• 게시판 리스트 옵션
  • 수정
  • 삭제

ADHD Medication During Pregnancy and Breastfeeding

The decision to stop or continue ADHD medication during breastfeeding and pregnancy is a difficult decision for women suffering from the condition. There is a lack of information about how long-term exposure to these medications could affect the foetus.

A recent study published in Molecular Psychiatry shows that children exposed to ADHD medication in the uterus do not develop neurological disorders like impaired vision or hearing, febrile seizures, or IQ impairment. The authors acknowledge the need for more high-quality research.

Risk/Benefit Analysis

Women who are expecting and taking ADHD medication should weigh the benefits of taking it versus the risks to the fetus. Doctors don't have the data needed to provide clear recommendations but they can provide information on benefits and risks that can assist pregnant women in making informed decisions.

A study published in Molecular Psychiatry found that women who were taking ADHD medications during early pregnancy did not face an increased risk of fetal cardiac malformations or major birth defects that are structural. Researchers used a large sample-based case control study to examine the prevalence of structural defects that were major in infants who were born to mothers who took stimulants during pregnancy. Clinical geneticists and pediatric cardiologists looked over the cases to ensure an accurate classification of the cases and to reduce the chance of bias.

However, the researchers' study had its limitations. Researchers were unable in the beginning, to separate the effects of the medication from the disorder. This makes it difficult to know whether the small associations observed in the groups that were exposed result from medication use or comorbidities that cause confusion. Researchers also did not examine the long-term effects for the offspring.

The study showed that babies whose mothers had taken ADHD medication during pregnancy had a greater risk of being admitted to the neonatal care unit (NICU), compared to mothers who did not take any medication during pregnancy or discontinued taking their medication prior to or during pregnancy. The reason for this was central nervous system disorders. The increased risk of admission was not influenced by the stimulant medications used during pregnancy.

Women who were taking stimulant ADHD medications during pregnancy also had a higher likelihood of having caesarean sections or a baby that scored low on the Apgar scale (less than 7). These increases appear to be unrelated to the type of medication used during pregnancy.

The researchers suggest that the risk of a small amount with the use of ADHD medications during early pregnancy may be offset by the higher benefit for both mother and child of continuing treatment for the woman's disorder. Doctors should discuss with their patients about this issue and, if possible, help them develop coping strategies that can lessen the effects of her disorder on her daily functioning and her relationships.

Interactions with Medication

More and more doctors are faced with the decision of whether to continue treatment or stop during pregnancy as more women are diagnosed with ADHD. The majority of these decisions are taken in the absence of any evidence that is clear and definitive either way, so physicians must weigh what they know from their own experiences, those of other doctors, and what the research says on the topic and their own best medication for anxiety depression and adhd judgment for each patient.

Particularly, the issue of potential risks for the infant can be difficult. A lot of studies on this issue are based on observations instead of controlled research and their findings are often contradictory. The majority of studies focus on live births, which can underestimate the teratogenic impact that can lead to terminations or abortions of pregnancy. The study presented in this journal club addresses these limitations by looking at data from both live and deceased births.

The conclusion The conclusion: While some studies have shown an association between ADHD medications and the possibility of certain birth defects, others have found no connection and the majority of studies demonstrate a neutral or slightly negative impact. As a result an accurate risk-benefit analysis must be conducted in every situation.

It can be difficult, if not impossible, for women with ADHD to stop taking their medication. In fact, in an article published in the Archives of Women's Mental Health psychologist Jennifer Russell notes that stopping ADHD medication during pregnancy can increase depression, feelings of isolation and family conflict for these patients. The loss of medication can affect the ability to safely drive and to perform work-related tasks which are essential aspects of everyday life for those suffering from ADHD.

She recommends women who are uncertain about whether or not to stop medication in light of their pregnancy should consider the possibility of educating friends, family members and colleagues on the condition, its effects on daily functioning, and the advantages of staying on the current treatment regimen. It will also help a woman feel more confident in her decision. Some medications can pass through the placenta. If the patient decides to not take her ADHD medication while pregnant and breastfeeding, it is crucial to be aware that the drug may be transferred to her baby.

Risk of Birth Defects

As the use and use of ADHD medications to treat the symptoms of attention deficit hyperactivity disorder (ADHD) is increasing, so does concern about the possible effects of the drugs on foetuses. Recent research published in the journal Molecular Psychiatry has added to the body knowledge on this subject. Utilizing two huge data sets researchers were able to examine more than 4.3 million pregnancies and determine whether stimulant medications increased the risk of birth defects. Although the risk overall is low, the researchers discovered that the first-trimester exposure to ADHD medications was linked to a slightly higher rate of certain heart defects, such as ventriculoseptal defect (VSD).

The researchers of the study could not discover any link between early medication usage and other congenital anomalies, such as facial deformities or club feet. The results are in the same vein as previous studies which showed the existence of a slight, but significant increase in cardiac malformations for women who started taking ADHD medication before the birth of their child. This risk increased during the latter part of pregnancy when a large number of women decided to stop taking their medication.

Women who used ADHD medications in the first trimester of their pregnancies were also more likely to experience a caesarean section, a low Apgar score after delivery and a baby that required breathing assistance during birth. The authors of the study were not able to eliminate bias due to selection because they limited their study to women who did not have any other medical conditions that might have contributed to the findings.

Researchers hope that their research will help doctors when they meet pregnant women. The researchers suggest that while discussing benefits and risks are crucial, the decision about whether to continue or stop medication should be in light of the severity of each woman's ADHD symptoms and her needs.

The authors also warn that even though stopping the medication is an alternative, it is not a recommended practice because of the high prevalence of depression and other mental health issues among women who are pregnant or who are recently post-partum. Additionally, the research suggests that women who decide to stop taking their medications are more likely to experience difficulties adapting to life without them following the baby's arrival.

Nursing

It can be overwhelming becoming a mother. Women suffering from ADHD may face a lot of challenges when they must deal with their symptoms, go to doctor appointments and prepare for the birth of a baby and adjust to new routines. Many women opt to continue taking their ADHD medication during pregnancy.

The majority of stimulant medications are absorbed through breast milk in small amounts, so the risk to the nursing infant is very low. However, the amount of exposure to medications by the infant can differ based on dosage, how often it is administered, and the time of the day the medication is administered. Additionally, Different types of adhd Medication medications enter the infant's system differently through the gastrointestinal tract as well as breast milk, and the effect of this on a newborn is not fully understood.

Because of the lack of research, some physicians may be inclined to discontinue stimulant medication during the pregnancy of a woman. This is a complicated decision for the patient, who must balance the benefit of continuing her medication against the possible dangers to the foetus. As long as there is no more information, doctors should inquire with all pregnant patients about their history of ADHD and whether they are taking or planning to take medication during the perinatal time.

Numerous studies have demonstrated that women can continue taking their adhd medication titration medication safely during pregnancy and breast-feeding. As a result, an increasing number of patients opt to do this, and in consultation with their physician, they have discovered that the benefits of keeping their current medication far outweigh any potential risks.

Women who suffer from ADHD who plan to breastfeed should seek advice from a specialist psychiatrist before becoming pregnant. They should review their medications with their prescriber and discuss the advantages and disadvantages of continued treatment, including non-pharmacological strategies. Psychoeducation is also required to help pregnant women suffering from ADHD be aware of the symptoms and the underlying disorder. They should also be informed about treatment options and strengthen coping mechanisms. This should be a multidisciplinary approach including obstetricians, GPs, and psychiatrists. The pregnancy counselling should consist of discussion of a management plan for both the mother as well as the child, as well as monitoring for signs of deterioration, and, if necessary, adjustments to the medication regimen.